Suono Bio, Inc. — Form D/A
Suono Bio, Inc. of FOXBOROUGH, MA, a company, filed a Form D amendment with the SEC on 2021-07-07. The offering totals $15.2M, of which $12.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-07-07
- Form: D/A
- Accession: 0001710229-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $15.2M
- Amount sold: $12.2M
- Remaining: $3.1M
- Investors: 11
- Date of first sale: 2021-03-19
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-393479
Issuer
- Name: Suono Bio, Inc.
- CIK: 0001710229
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 200 FOXBOROUGH BLVD, FOXBOROUGH, MA, 02035
- Phone: 617-299-1496
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Amy Schulman | Director | Cambridge, MA |
| Robert Langer | Director | Pittsburgh, PA |
| CARL SCHOELLHAMMER | Director | FOXBOROUGH, MA |
| CARL SCHOELLHAMMER | Executive Officer | FOXBOROUGH, MA |
| FREDERICK SHANE | Director | FOXBOROUGH, MA |
| GIOVANNI TRAVERSO | Director | FOXBOROUGH, MA |
| VICTORIA WANG | Director | FOXBOROUGH, MA |
| SCOTT KELLOGG | Director | FOXBOROUGH, MA |
| SCOTT KELLOGG | Executive Officer | FOXBOROUGH, MA |
Other filings by this issuer (3)
More